Reuters – The U.S. Food and Drug Administration has declined to approve PTC Therapeutics Inc’s experimental drug to treat Duchenne muscular dystrophy, saying an additional clinical trial would be needed to prove the drug works.
In this week’s Neuroscience SciPol Weekly, why autism affect boys more, the benefits of daydreaming, a new brain injury device, skewed samples in neuroscience research, and the story about the Sacklers family.
The Washington Post – Scott Gottlieb, commissioner of the Food and Drug Administration, called Wednesday for the expanded use of medication-assisted treatments for opioid addiction, saying they could reduce overdoses and deaths.
The Hill – The Trump administration is allowing state and local governments to significantly expand their drone operations, a step that is intended to accelerate the integration of unmanned aircraft into the national airspace.
The New York Times – President Trump on Thursday directed the Department of Health and Human Services to declare the opioid crisis a public health emergency, taking long-anticipated action to address a rapidly escalating epidemic of drug use.
MIT Technology Review – CRISPR-Cas9 can edit or delete whole genes. Now, scientists have developed a more precise version of the DNA-editing tool that can repair even smaller segments of a person’s genome.
STAT – The Trump administration is poised to declare the opioid epidemic a national emergency on Thursday, following through on a recommendation made nearly three months ago by a special White House commission tasked with addressing the crisis.
Department of Transportation – President Trump directed U.S. Secretary of Transportation Elaine L. Chao to launch an initiative to safely test and validate advanced operations for drones in partnership with state and local governments in select jurisdictions.